Back to all studies
🩸
Phase 3
Cholesterol
in-person
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Sponsored by Merck Sharp & Dohme LLC
Compensation
$500–$2,500
Duration
3 months
Location
Nationwide
About this study
Researchers designed a study medicine called enlicitide to lower low-density lipoprotein cholesterol (LDL-C). In this study, researchers want to learn about giving enlicitide with another medicine called rosuvastatin. Rosuvastatin is a standard (usual) treatment to lower LDL-C. The goal of this study is to learn if enlicitide given with rosuvastatin works better than placebo on lowering LDL-C in a person's blood. A placebo looks like the study medicine but has no study medicine in it. Using a…
Who can participate
- • Adults aged 18–64
- • All genders welcome
- • Diagnosed with or experiencing hyperlipidemia
- • Able to attend in-person clinic visits
What's included
- • Compensation up to $2,500
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Paid Study?
Join over 100,000 people who have been matched with clinical studies. It's free, fast, and could change your life.